SAB Biotherapeutics Inc
(NAS:SABS)
$
3.695
-0.050 (-1.33%)
Market Cap: 336.19 Mil
Enterprise Value: 238.69 Mil
PE Ratio: 0
PB Ratio: 1.44
GF Score: 30/100 Recent Filings
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Financials
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Ownership
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Material News Releases
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Proxy
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Others
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||